DANIEL SABATER HERNÁNDEZ-rekin lankidetzan egindako argitalpenak (30)

2021

  1. Estudio de prevalencia de uso de la terapia Triple Whammy en farmacia comunitaria

    Ars pharmaceutica, Vol. 62, Núm. 1, pp. 40-40

2020

  1. Collaborative health service planning: A stakeholder analysis with social network analysis to develop a community pharmacy service

    Research in Social and Administrative Pharmacy, Vol. 16, Núm. 2, pp. 216-229

  2. Stakeholder analysis in health innovation planning processes: A systematic scoping review

    Health Policy, Vol. 124, Núm. 10, pp. 1083-1099

2017

  1. Cost analysis and cost-benefit analysis of a medication review with follow-up service in aged polypharmacy patients

    European Journal of Health Economics, Vol. 18, Núm. 9, pp. 1069-1078

  2. Cost analysis for the implementation of a medication review with follow-up service in Spain

    International Journal of Clinical Pharmacy, Vol. 39, Núm. 4, pp. 750-758

  3. Modelling elderly patients’ perception of the community pharmacist image when providing professional services*

    Psychology, Health and Medicine, Vol. 22, Núm. 5, pp. 578-587

  4. Patients' expectations of the role of the community pharmacist: Development and testing of a conceptual model

    Research in Social and Administrative Pharmacy, Vol. 13, Núm. 2, pp. 313-320

2016

  1. Healthcare professional-patient relationships: Systematic review of theoretical models from a community pharmacy perspective

    Patient Education and Counseling, Vol. 99, Núm. 3, pp. 339-347

  2. Intervention mapping for developing pharmacy-based services and health programs: A theoretical approach

    American Journal of Health-System Pharmacy

2015

  1. Assessment of a screening protocol for type 2 diabetes in community pharmacy. The DiabNow Study

    Diabetes Research and Clinical Practice, Vol. 108, Núm. 3, pp. e49-e52

  2. Cost-Utility Analysis of a Medication Review with Follow-Up Service for Older Adults with Polypharmacy in Community Pharmacies in Spain: The conSIGUE Program

    PharmacoEconomics, Vol. 33, Núm. 6, pp. 599-610

  3. Identifying masked uncontrolled hypertension in the community pharmacy setting

    Blood Pressure Monitoring, Vol. 20, Núm. 3, pp. 138-143

  4. Validity of home blood pressure measurements manually registered by patients after an educational session provided by community pharmacists

    Blood Pressure Monitoring, Vol. 20, Núm. 4, pp. 232-236

2014

  1. Lifestyles habits and sleep quality in patients over the age of 65 attending community pharmacies

    Latin American Journal of Pharmacy, Vol. 33, Núm. 5, pp. 739-745

2013

  1. Effect of a pharmacist intervention on asthma control. A cluster randomised trial

    Respiratory Medicine, Vol. 107, Núm. 9, pp. 1346-1355

  2. Get Impact Program. Evaluation clinical impact, economic and humanistic Pharmacotherapy follow adults greater polypharmacy

    Vitae

  3. Impact of a community pharmacists' hypertension-care service on medication adherence. The AFenPA study

    Research in Social and Administrative Pharmacy, Vol. 9, Núm. 6, pp. 797-805

  4. Investigación y conocimiento en Atención Farmacéutica: un binomio inseparable

    Ars pharmaceutica, Vol. 54, Núm. 2, pp. 1-3

  5. Relationship between urinary albumin excretion and blood pressure in the community pharmacy: The palmera study

    American Journal of Hypertension

2012

  1. Agreement between community pharmacy, physician's office, and home blood pressure measurement Methods : the palmera study

    American Journal of Hypertension, Vol. 25, Núm. 3, pp. 290-296